Ikena Oncology, Inc. (IKNA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 10:22AM EDT. Market open.
| Previous close | 1.6800 |
| Open | 1.6700 |
| Bid | 1.6500 x 100 |
| Ask | 1.7000 x 200 |
| Day's range | 1.6500 - 1.7000 |
| 52-week range | 1.0200 - 7.0000 |
| Volume | |
| Avg. volume | 304,979 |
| Market cap | 80.832M |
| Beta (5Y monthly) | 0.49 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
It's Unlikely That Ikena Oncology, Inc.'s (NASDAQ:IKNA) CEO Will See A Huge Pay Rise This Year
Key Insights Ikena Oncology's Annual General Meeting to take place on 7th of June CEO Mark Manfredi's total...
- Simply Wall St.
Ikena Oncology Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
Ikena Oncology ( NASDAQ:IKNA ) Full Year 2023 Results Key Financial Results Net loss: US$68.2m (flat on FY 2022...
- Zacks
Down -29.05% in 4 Weeks, Here's Why Ikena Oncology, Inc. (IKNA) Looks Ripe for a Turnaround
The heavy selling pressure might have exhausted for Ikena Oncology, Inc. (IKNA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
© 2024 Yahoo. All rights reserved.